OXA1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.601920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.077160E-01
Normal-vs-Stage2
1.732440E-02
Normal-vs-Stage3
9.586000E-02
Normal-vs-Stage4
3.084000E-01
Stage1-vs-Stage2
4.633400E-01
Stage1-vs-Stage3
6.476000E-01
Stage1-vs-Stage4
4.690600E-01
Stage2-vs-Stage3
1.344810E-01
Stage2-vs-Stage4
4.643000E-01
Stage3-vs-Stage4
3.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.594210E-02
Normal-vs-AfricanAmerican
2.839200E-01
Normal-vs-Asian
1.737950E-02
Caucasian-vs-AfricanAmerican
4.351400E-01
Caucasian-vs-Asian
8.982200E-01
AfricanAmerican-vs-Asian
5.034600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.124420E-02
Normal-vs-Female
2.941600E-02
Male-vs-Female
7.583400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.761800E-02
Normal-vs-Age(41-60Yrs)
2.450400E-02
Normal-vs-Age(61-80Yrs)
1.331550E-02
Normal-vs-Age(81-100Yrs)
9.902300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.11210000000173E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.807630E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.415800E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.566300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.186200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.620100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.960400E-03
Normal-vs-Daily Drinker
5.091700E-02
Normal-vs-Weekly Drinker
2.934200E-02
Normal-vs-Occasional Drinker
3.828300E-02
Normal-vs-Social Drinker
4.861700E-02
Non Drinker-vs-Daily Drinker
5.482600E-01
Non Drinker-vs-Weekly Drinker
8.289600E-01
Non Drinker-vs-Occasional Drinker
1.736170E-01
Non Drinker-vs-Social Drinker
9.950000E-02
Daily Drinker-vs-Weekly Drinker
7.728600E-01
Daily Drinker-vs-Occasional Drinker
5.293200E-01
Daily Drinker-vs-Social Drinker
3.674600E-01
Weekly Drinker-vs-Occasional Drinker
3.512000E-01
Weekly Drinker-vs-Social Drinker
2.268200E-01
Occasional Drinker-vs-Social Drinker
7.258200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.821800E-01
Normal-vs-Grade 2
7.966600E-01
Normal-vs-Grade 3
7.834600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.674800E-01
Grade 1-vs-Grade 3
1.381410E-01
Grade 1-vs-Grade 4
8.821800E-01
Grade 2-vs-Grade 3
7.776800E-01
Grade 2-vs-Grade 4
7.966600E-01
Grade 3-vs-Grade 4
7.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.667800E-02
Normal-vs-NonDiabetic
7.384900E-03
Diabetic-vs-NonDiabetic
7.963600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.123700E-02
Normal-vs-NoPancreatitis
7.895900E-03
Pancreatitis-vs-NoPancreatitis
9.813400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.643700E-02
Normal-vs-N1
1.066080E-02
N0-vs-N1
5.956800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.092210E-01
Normal-vs-TP53-NonMutant
9.710200E-02
TP53-Mutant-vs-TP53-NonMutant
1.871210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
